Lupron Depot 3.75 mg (Leuprolide Acetate POWDER FOR SUSPENSION, SUSTAINED-RELEASE) 3.75 MG

LUPRON DEPOT 3.75 MG is a sustained-release formulation of leuprolide acetate, used for hormone-related conditions. This intramuscular powder for suspension is manufactured by AbbVie Corporation in Canada.

Strength

3.75 MG

Pack Size

Manufacturer / TM Owner

ABBVIE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LUPRON DEPOT 3.75 MG is primarily used for managing hormone-sensitive conditions. It works by reducing the levels of certain hormones in the body. Common applications include the treatment of endometriosis, uterine fibroids, and prostate cancer. Leuprolide acetate is often prescribed to control symptoms associated with these conditions, such as pain and abnormal growths.

Side Effects

LUPRON DEPOT 3.75 MG may cause common side effects such as hot flashes, headaches, and injection site reactions. Some users may experience changes in mood or energy levels. It is important to discuss any persistent or severe side effects with a healthcare provider.

Precautions & Warnings

LUPRON DEPOT 3.75 MG should be handled with care and administered as directed by a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before using this medication. Proper storage and handling are essential to maintain its effectiveness.

Avoid Interactions

LUPRON DEPOT 3.75 MG may interact with other medications, including those that affect hormone levels. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and certain supplements may also interact with leuprolide acetate, so it is important to discuss all current medications with a healthcare professional.

Frequently Asked Questions

LUPRON DEPOT 3.75 MG is used to manage hormone-sensitive conditions such as endometriosis, uterine fibroids, and prostate cancer.

LUPRON DEPOT 3.75 MG is administered intramuscularly as a powder for suspension.

Common side effects may include hot flashes, headaches, and injection site reactions.

It is important to consult a healthcare provider before combining LUPRON DEPOT 3.75 MG with other medications.

LUPRON DEPOT 3.75 MG is manufactured by AbbVie Corporation in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.